BGF-31792-15314
3 vaccinations
8 coded responses
30 check-ins
8 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 328 / FL
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Survey response — day 0, dose 1MedDRA: Myalgia — Feeling: Good · Site: PainFree text: Minor soreness in muscle receiving injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Mild muscle pain at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain, Myalgia — Feeling: Good · Site: PainFree text: Minor muscle pain at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Mild pain in muscle at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-28
-
2021-02-04
Dose 2 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-05
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Injection site pain — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Significant fatigue, other than that mild pain at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Injection site erythema, Injection site pain — Feeling: Fair · Site: Pain, Redness · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Moderate fatigue coupled w minor pain at injection site and moderate redness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-05-08
- 2021-08-05
-
2022-01-12
Dose 3 — Pfizer-BioNTech
- 2022-02-04
-
2022-02-04
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesFree text: I caught a Covid 19 infection in November 2021.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Survey response — day 28, dose 3MedDRA: Nasopharyngitis, Pre-existing disease, Respiratory tract congestion, Sneezing — Feeling: FairFree text: Sneezing and congestion, but just either head cold or allergies. only head no other difficulties.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-16
- 2022-02-23
- 2022-04-13
- 2022-07-17
- 2023-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2022-01-12 | Pfizer-BioNTech | No |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Minor soreness in muscle receiving injection
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Mild muscle pain at injection site
Systemic reaction (other): Minor muscle pain at injection site
Systemic reaction (other): Mild pain in muscle at injection site
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Significant fatigue, other than that mild pain at injection site
Systemic reaction (other): Moderate fatigue coupled w minor pain at injection site and moderate redness at injection site
Release 11 — 12 months, dose 2
Symptoms: I caught a Covid 19 infection in November 2021.
Release 11 — day 28, dose 3
Symptoms: Sneezing and congestion, but just either head cold or allergies. only head no other difficulties.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release